Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19
Completed
Conditions studied: Coronavirus
In brief
The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
Key facts
- Study ID
- NCT04373148
- Run by
- Stanford University
- People needed
- 316
- Starts
- 2020-04-08
- Expected to finish
- 2022-05-31
- Last updated by the study team
- 2022-06-15
Who can join
Age: 2 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adults (18 years and older) and children with confirmed COVID-19 (RT-PCR diagnosis).
- Adults (18 years and older) and children without COVID-19 for controls (who test negative for COVID-19 but may have viral symptoms)
You may not qualify if…
- Patients with special risks attendant to venipuncture will be excluded.
Where it is running
- Stanford Health Care - ValleyCare — Pleasanton, California, United States
- Stanford University, Hospital, and Clinics — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.